These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 888639

  • 1. Identification of short time intervals under LSD25 and mescaline.
    Mitrani L, Shekerdjiiski S, Gourevitch A, Yanev S.
    Act Nerv Super (Praha); 1977 May; 19(2):103-4. PubMed ID: 888639
    [No Abstract] [Full Text] [Related]

  • 2. Identification of time intervals under LSD25 and mescaline.
    Mitrani L, Shekerdjiiski S, Gurevich A, Yanev S.
    C R Acad Bulg Sci; 1977 May; 30(11):1645-7. PubMed ID: 608407
    [No Abstract] [Full Text] [Related]

  • 3. Effect of mescaline and lysergic acid diethylamide on flicker discrimination in the rat.
    Schechter MD, Winter JC.
    J Pharmacol Exp Ther; 1971 May; 177(2):461-7. PubMed ID: 5568801
    [No Abstract] [Full Text] [Related]

  • 4. Patterns of tolerance to lysergic acid diethylamide and mescaline in rats.
    FREEDMAN DX, AGHAJANIAN GK, ORNITZ EM.
    Science; 1958 May 16; 127(3307):1173-4. PubMed ID: 13555858
    [No Abstract] [Full Text] [Related]

  • 5. Antidiuresis in man following lysergic acid diethylamide and mescaline.
    Hollister LE, Kanter SL, Dronkert A.
    Behav Neuropsychiatry; 1970 May 16; 2(3):50-4. PubMed ID: 4913153
    [No Abstract] [Full Text] [Related]

  • 6. PSYCHODYNAMIC and therapeutic aspects of mescaline and lysergic acid diethylamide: round table.
    J Nerv Ment Dis; 1957 May 16; 125(3):423-4. PubMed ID: 13481746
    [No Abstract] [Full Text] [Related]

  • 7. Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat.
    Tilson HA, Sparber SB.
    J Pharmacol Exp Ther; 1973 Feb 16; 184(2):376-84. PubMed ID: 4688175
    [No Abstract] [Full Text] [Related]

  • 8. [Influence of mescaline and of lysergic acid diethylamide (LSD-25) on the development of primary and secondary conditioned avoidance reflexes in rats].
    MAFFII G.
    Farmaco Sci; 1959 Jul 16; 14():503-15. PubMed ID: 13853753
    [No Abstract] [Full Text] [Related]

  • 9. Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component.
    Winter JC.
    J Pharmacol Exp Ther; 1971 Sep 16; 178(3):625-30. PubMed ID: 5571911
    [No Abstract] [Full Text] [Related]

  • 10. Prolonged survival of the isolated retina induced by drugs; strychnine, mescaline, d-lysergic acid diethylamide (LSD), and atropine.
    APTER JT.
    AMA Arch Ophthalmol; 1958 May 16; 59(5):722-30. PubMed ID: 13519998
    [No Abstract] [Full Text] [Related]

  • 11. [Change in complex forms of conditioned reflexes caused by the application of lysergic acid diethylamide (LSD) and mescaline to the cortical ends of the auditory and visual analyzers].
    Alekseeva LA.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1969 May 16; 19(2):279-85. PubMed ID: 5404353
    [No Abstract] [Full Text] [Related]

  • 12. [Similarities and dissimilarities of experimental psychoses caused by LSD-25 and mescaline].
    VOJTECHOVSKY M, GROF S.
    Cesk Psychiatr; 1960 Aug 16; 56():221-33. PubMed ID: 13781932
    [No Abstract] [Full Text] [Related]

  • 13. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI.
    Science; 1976 May 21; 192(4241):801-3. PubMed ID: 1063447
    [Abstract] [Full Text] [Related]

  • 14. Correlation of rhinencephalic electrograms with behavior; a study on humans under the influence of LSD and mescaline.
    MONROE RR, HEATH RG, MICKLE WA, LLEWELLYN RC.
    Electroencephalogr Clin Neurophysiol; 1957 Nov 21; 9(4):623-42. PubMed ID: 13480236
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.